{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:19:08Z","timestamp":1760059148495,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["RC 13\/24"],"award-info":[{"award-number":["RC 13\/24"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Methylmalonic acidemia combined with homocystinuria (cblC) can lead to infantile maculopathy. Although significant visual deterioration is commonly reported in early-onset cblC, we found poor awareness regarding formal assessments of ocular complications, especially in newborns, and of how these complications relate to the timing of therapy initiation. In this work, we present our experience and perform a literature review. Methods: We performed sequential fundus examinations, optical coherence tomography (OCT) and full-field electroretinography (ERG) under sedation following detection of signs of retinal degeneration. We also assessed visual fields using kinetic attraction perimetry. Results: We report a newborn who was referred on the eighth day of life, following a diagnosis of cblC through newborn screening (NBS), and who began treatment that same day. Close monitoring of retinal changes through fundus examinations allowed the detection of signs of retinal degeneration at 3 months, which progressed when checked at 5 months. At 7 months, OCT showed retinal thinning with the appearance of bull\u2019s eye maculopathy in the corresponding region on fundoscopy; ERG revealed a reduction in the amplitude of both scotopic and photopic components, whereas kinetic attraction perimetry showed no abnormalities. Genetic investigation confirmed the disease, compound heterozygous for a nonsense variant in MMACHC and a splicing one in PRDX1. Conclusions: In cblC, retinal degeneration occurs in the first months of life despite timely treatment and adequate biochemical control, and it may manifest before any signs of visual deprivation appear. However, there is an early, narrow window during which therapy may slow down retinal degeneration enough to prevent sensory nystagmus. We recommend initiating therapy immediately after biochemical diagnosis, along with close ophthalmological monitoring, before the appearance of any signs.<\/jats:p>","DOI":"10.3390\/genes16060635","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:39:36Z","timestamp":1748205576000},"page":"635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal Changes in Early-Onset cblC Methylmalonic Acidemia Identified Through Expanded Newborn Screening: Highlights from a Case Study and Literature Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4313-2917","authenticated-orcid":false,"given":"Paola","family":"Michieletto","sequence":"first","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-3154","authenticated-orcid":false,"given":"Francesco","family":"Baldo","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Madonia","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5886-9129","authenticated-orcid":false,"given":"Luisa","family":"Zupin","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6699-8455","authenticated-orcid":false,"given":"Stefano","family":"Pensiero","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-0482","authenticated-orcid":false,"given":"Maria Teresa","family":"Bonati","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health \u201cBurlo Garofolo\u201d, 34137 Trieste, TS, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ruoppolo, M., Malvagia, S., Boenzi, S., Carducci, C., Dionisi-Vici, C., Teofoli, F., Burlina, A., Angeloni, A., Aronica, T., and Bordugo, A. (2022). Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8030047"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41467-017-02306-5","article-title":"APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients","volume":"9","author":"Oussalah","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ymgme.2015.01.012","article-title":"Ocular disease in the cobalamin C defect: A review of the literature and a suggested framework for clinical surveillance","volume":"114","author":"McCourt","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e63953","DOI":"10.1002\/ajmg.a.63953","article-title":"Does It Run in Your Family? Inherited Truncating PSMD12 Variants Broaden the Phenotypic Spectrum of Stankiewicz-Isidor Syndrome","volume":"197","author":"Feresin","year":"2024","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/joco.joco_197_22","article-title":"Comparison of Visual Field Measurements in Glaucomatous Eyes using Oculus and Metrovision Perimeters","volume":"35","author":"Daneshvar","year":"2023","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_7","first-page":"29","article-title":"Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient","volume":"35","author":"Maines","year":"2017","journal-title":"JIMD Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ophtha.2013.08.034","article-title":"Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type","volume":"121","author":"Gizicki","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13148-021-01117-2","article-title":"PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations","volume":"13","author":"Cavicchi","year":"2021","journal-title":"Clin. Epigenet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/13816810.2015.1121500","article-title":"Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia","volume":"37","author":"Ku","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaapos.2012.02.019","article-title":"Ocular manifestations of cobalamin C type methylmalonic aciduria with homocystinuria","volume":"16","author":"Fuchs","year":"2012","journal-title":"J. AAPOS"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-020-01485-7","article-title":"Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: Long term follow-up in a large cohort of cases","volume":"15","author":"He","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"805599","DOI":"10.3389\/fgene.2022.805599","article-title":"The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening","volume":"13","author":"Ling","year":"2022","journal-title":"Front. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10545-011-9365-x","article-title":"Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes","volume":"35","author":"Venditti","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/13816810.2015.1010736","article-title":"Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull\u2019s Eye Maculopathy","volume":"36","author":"Collison","year":"2015","journal-title":"Ophthalmic Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"166201","DOI":"10.1016\/j.bbadis.2021.166201","article-title":"Absence of MMACHC in peripheral retinal cells does not lead to an ocular phenotype in mice","volume":"1867","author":"Kiessling","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13816810.2014.885059","article-title":"Retinal Structure in Cobalamin C Disease: Mechanistic and Therapeutic Implications","volume":"36","author":"Aleman","year":"2015","journal-title":"Ophthalmic Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10545-013-9605-3","article-title":"Glutathione metabolism in cobalamin deficiency type C (cblC)","volume":"37","author":"Pastore","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1308289","DOI":"10.3389\/fneur.2023.1308289","article-title":"Late-onset cobalamin C deficiency type in adult with cognitive and behavioral disturbances and significant cortical atrophy and cerebellar damage in the MRI: A case report","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.diff.2023.04.003","article-title":"Abnormal chondrocyte development in a zebrafish model of cblC syndrome restored by an MMACHC cobalamin binding mutant","volume":"131","author":"Paz","year":"2023","journal-title":"Differentiation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00431-010-1371-8","article-title":"Cobalamin C defect presenting as severe neonatal hyperammonemia","volume":"170","author":"Martinelli","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/01913913-20090918-10","article-title":"Maculopathy Due to Cobalamin C (cb1C) Disease in an Amish Child","volume":"47","author":"Grant","year":"2010","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgme.2013.07.018","article-title":"Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type","volume":"110","author":"Bender","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13816810500481758","article-title":"The natural history of retinal degeneration in association with cobalamin C (cbl C) disease","volume":"27","author":"Schimel","year":"2006","journal-title":"Ophthalmic Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-2008-1027310","article-title":"Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: A spectrum of disorders","volume":"225","author":"Gaillard","year":"2008","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jimd.12009","article-title":"Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation","volume":"42","author":"Froese","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zeviani, M., and Carelli, V. (2021). Mitochondrial Retinopathies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010210"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2009.229","article-title":"Inherited metabolic disorders involving the eye: A clinico-biochemical perspective","volume":"24","author":"Rajappa","year":"2010","journal-title":"Eye"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Fagerberg","year":"2015","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"110286","DOI":"10.1016\/j.ygeno.2022.110286","article-title":"The Human Eye Transcriptome Atlas: A searchable comparative transcriptome database for healthy and diseased human eye tissue","volume":"114","author":"Wolf","year":"2022","journal-title":"Genomics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9394(14)71578-8","article-title":"Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria","volume":"113","author":"Traboulsi","year":"1992","journal-title":"Am. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13052-019-0760-5","article-title":"Early onset retinal dystrophies: Clinical clues to diagnosis for pediatricians","volume":"45","author":"Suppiej","year":"2019","journal-title":"Ital. J. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaapos.2008.06.008","article-title":"Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type","volume":"12","author":"Gerth","year":"2008","journal-title":"J. AAPOS"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-022-02179-y","article-title":"Adult-onset CblC deficiency: A challenging diagnosis involving different adult clinical specialists","volume":"17","author":"Kalantari","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/acs.molpharmaceut.8b00617","article-title":"Investigation of Receptor-Mediated Cyanocobalamin (Vitamin B12) Transport across the Inner Blood-Retinal Barrier Using Fluorescence-Labeled Cyanocobalamin","volume":"15","author":"Kinoshita","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10545-007-0760-2","article-title":"Amnionless (AMN) mutations in Imerslund-Gr\u00e4sbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS","volume":"31","author":"Luder","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12787","DOI":"10.1002\/jimd.12787","article-title":"Improved biochemical and neurodevelopmental profiles with high-dose hydroxocobalamin therapy in cobalamin C defect","volume":"48","author":"Olivieri","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"107681","DOI":"10.1016\/j.ymgme.2023.107681","article-title":"Would, early, versus late hydroxocobalamin dose intensification treatment, prevent cognitive decline, macular degeneration and ocular disease, in 5 patients with early-onset cblC deficiency?","volume":"140","author":"Scalais","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101966","DOI":"10.1016\/j.gimo.2025.101966","article-title":"O03: Hydroxocobalamin (OHCbl) dose intensification can prevent visual deterioration and improve neurological and biochemical outcomes in CBLC deficiency","volume":"3","author":"Venditti","year":"2025","journal-title":"Genet. Med. Open"},{"key":"ref_40","first-page":"102","article-title":"Outcomes of patients with cobalamin C deficiency: A single center experience","volume":"57","author":"Bourque","year":"2020","journal-title":"JIMD Rep."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:13Z","timestamp":1760031613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/6\/635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["genes16060635"],"URL":"https:\/\/doi.org\/10.3390\/genes16060635","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2025,5,25]]}}}